History

 

1995

Foundation 100% Frauendorfer ex Wellcome Manager

1996

Agreement with GSK Epoprostenol/Flolan^® (on the basis of named patient § 73/3 AMG)

1997

Development of a pharmaceutical formulation of Ribavirin capsules for therapy of Hepatitis C

2001

Agreement with Axcan Canada. Photofrin^® for Photodynamic Therapy (PDT)

2001

Marketing and Distribution of Haemopressin^® (Terlipressin)

2002

EU patent granted for Xylose stomach resistant capsule technology

2004

Takeover of Asacol^® (Mesalazine) from Sanofi

2008

Launch of Medunasal^® -Heparin 500 I.U. to block intravenous catheter and port systems

2010

Launch of Takipril^® Prilocain hyperbar 2%, used for Spinal Anaesthesia